TAUNS Laboratories, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3452250008
JPY
529.00
5 (0.95%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
5,908.17
2,368.41
1,020.07
5,626.89
5,561.40
6,419.62
2,063.17
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
5,908.17
2,368.41
1,020.07
5,626.89
5,561.40
6,419.62
2,063.17
Raw Material Cost
1,907.54
738.40
930.28
1,662.60
1,651.32
1,608.80
875.17
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
61.20
50.75
38.11
31.28
17.74
15.78
117.15
Selling and Distribution Expenses
1,295.88
1,082.48
1,155.50
1,172.05
1,116.80
1,065.62
1,076.21
Other Expenses
-6.12
-5.08
-3.81
-3.13
-1.77
-1.58
19.06
Total Expenditure (Excl Depreciation)
3,203.42
1,820.89
2,085.77
2,834.65
2,768.12
2,674.42
2,259.16
Operating Profit (PBDIT) excl Other Income
2704.7000000000003
547.5
-1065.6999999999998
2792.2000000000003
2793.2999999999997
3745.2
-196
Other Income
-2.21
9.41
7.87
10.25
-4.23
25.86
-96.70
Operating Profit (PBDIT)
2,909.17
739.37
-875.68
2,985.68
2,967.17
3,943.03
-123.21
Interest
61.20
50.75
38.11
31.28
17.74
15.78
117.15
Exceptional Items
-241.40
0.00
0.00
0.00
0.00
0.00
-1.61
Gross Profit (PBDT)
4,000.63
1,630.01
89.80
3,964.30
3,910.08
4,810.83
1,188.00
Depreciation
206.63
182.44
182.15
183.18
178.13
171.97
169.48
Profit Before Tax
2,399.94
506.19
-1,095.94
2,771.22
2,771.31
3,755.29
-411.45
Tax
697.27
148.28
-765.85
812.60
781.12
1,058.60
-279.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,702.67
357.90
-330.09
1,958.62
1,990.19
2,696.69
-132.45
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,702.67
357.90
-330.09
1,958.62
1,990.19
2,696.69
-132.45
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,702.67
357.90
-330.09
1,958.62
1,990.19
2,696.69
-132.45
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
17,405.97
15,518.38
17,417.67
17,672.05
16,291.14
14,252.00
13,666.76
Earnings per share (EPS)
15.85
3.33
-3.21
17.94
18.55
25.2
-1.32
Diluted Earnings per share
15.85
3.33
-3.21
17.94
18.55
25.2
-1.32
Operating Profit Margin (Excl OI)
45.78%
23.12%
-104.47%
49.62%
50.23%
58.34%
-9.5%
Gross Profit Margin
44.12%
29.08%
-89.58%
52.51%
53.03%
61.18%
-11.73%
PAT Margin
28.82%
15.11%
-32.36%
34.81%
35.79%
42.01%
-6.42%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Markets Mojo
Analysis not available
Compare Quarterly Results Of TAUNS Laboratories, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
5,908.17
0
5,908.17
Other Operating Income
0.00
0.00
0.00
Total Operating income
5,908.17
0
5,908.17
Raw Material Cost
1,907.54
0
1,907.54
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
61.20
0
61.20
Selling and Distribution Expenses
1,295.88
0
1,295.88
Other Expenses
-6.12
0.00
-6.12
Total Expenditure (Excl Depreciation)
3,203.42
0
3,203.42
Operating Profit (PBDIT) excl Other Income
2,704.75
0.00
2,704.75
Other Income
-2.21
0
-2.21
Operating Profit (PBDIT)
2,909.17
0
2,909.17
Interest
61.20
0
61.20
Exceptional Items
-241.40
0
-241.40
Gross Profit (PBDT)
4,000.63
0
4,000.63
Depreciation
206.63
0
206.63
Profit Before Tax
2,399.94
0
2,399.94
Tax
697.27
0
697.27
Provisions and contingencies
0
0
0.00
Profit After Tax
1,702.67
0
1,702.67
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,702.67
0
1,702.67
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,702.67
0
1,702.67
Equity Capital
0
0
0.00
Face Value
0.00
0
0.00
Reserves
17,405.97
0
17,405.97
Earnings per share (EPS)
15.85
0
15.85
Diluted Earnings per share
15.85
0
15.85
Operating Profit Margin (Excl OI)
45.78%
0%
0.00
45.78%
Gross Profit Margin
44.12%
0%
0.00
44.12%
PAT Margin
28.82%
0%
0.00
28.82%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales NA Million
in

Figures in Million
stock-summary

stock-summary

Quarterly - Standalone Net Profit
Standalone Net Profit NA Million
in

Figures in Million
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) NA Million
in

Figures in Million
Quarterly - Interest
Interest NA Million
in

Figures in Million
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) NA%
in

Figures in %